UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lowered by New Century Financial Group LLC

New Century Financial Group LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.0% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,215 shares of the healthcare conglomerate’s stock after selling 120 shares during the period. New Century Financial Group LLC’s holdings in UnitedHealth Group were worth $636,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at about $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $32,000. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director John H. Noseworthy purchased 300 shares of the firm’s stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the purchase, the director now directly owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $313.39 on Friday. The firm has a market cap of $284.28 billion, a PE ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.45. The firm’s 50 day moving average price is $386.66 and its 200 day moving average price is $474.19. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the business earned $6.91 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.82%. The ex-dividend date is Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Truist Financial restated a “buy” rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Barclays reduced their price objective on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. Finally, KeyCorp reduced their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.